| Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers, X Cao, Y Ning, ... Cell 173 (7), 1770-1782. e14, 2018 | 558 | 2018 |
| Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer Q Wang, Z Huang, S Ni, X Xiao, Q Xu, L Wang, D Huang, C Tan, W Sheng, ... Public Library of Science 7 (9), e44398, 2012 | 272 | 2012 |
| Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression Y Zhang, S Pitchiaya, M Cieślik, YS Niknafs, JCY Tien, Y Hosono, MK Iyer, ... Nature genetics 50 (6), 814-824, 2018 | 218 | 2018 |
| Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis X Xiao, M Hao, X Yang, Q Ba, M Li, S Ni, LS Wang, X Du Cancer letters 302 (1), 69-75, 2011 | 185 | 2011 |
| MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma Z Huang, S Huang, Q Wang, L Liang, S Ni, L Wang, W Sheng, X He, X Du Cancer research 71 (7), 2582-2589, 2011 | 170 | 2011 |
| Biomarkers in bladder cancer: translational and clinical implications L Cheng, DD Davison, J Adams, A Lopez-Beltran, L Wang, R Montironi, ... Critical reviews in oncology/hematology 89 (1), 73-111, 2014 | 113 | 2014 |
| microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma Q Wang, Z Huang, W Guo, S Ni, X Xiao, L Wang, D Huang, C Tan, Q Xu, ... Clinical Cancer Research 20 (5), 1146-1157, 2014 | 90 | 2014 |
| Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical … SL Skala, H Xiao, AM Udager, SM Dhanasekaran, S Shukla, Y Zhang, ... Modern Pathology 31 (1), 179-197, 2018 | 89 | 2018 |
| Neuroendocrine tumors of the prostate: emerging insights from molecular data and updates to the 2016 World Health Organization classification DS Priemer, R Montironi, L Wang, SR Williamson, A Lopez-Beltran, ... Endocrine pathology 27, 123-135, 2016 | 88 | 2016 |
| Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer. DX Xiao X, Wang L, Wei P, Chi Y, Li D, Wang Q, Ni S, Tan C, Sheng W, Sun M ... J Transl Med, 2013 | 88 | 2013 |
| Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer Y Qiao, JE Choi, JC Tien, SA Simko, T Rajendiran, JN Vo, AD Delekta, ... Nature cancer 2 (9), 978-993, 2021 | 81 | 2021 |
| FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL P Wei, N Zhang, Y Wang, D Li, L Wang, X Sun, C Shen, Y Yang, X Zhou, ... International journal of biological sciences 11 (2), 186, 2015 | 76 | 2015 |
| Next-generation RNA sequencing–based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms SL Skala, X Wang, Y Zhang, R Mannan, L Wang, SP Narayanan, P Vats, ... European urology 78 (1), 63-74, 2020 | 73 | 2020 |
| MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer DX Ren F, Wang L, Shen X, Xiao X, Liu Z, Wei P, Wang Y, Qi P, Shen C, Sheng W Am J Cancer Res, 2015 | 70 | 2015 |
| Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with … L Cheng, DD Davidson, M Wang, A Lopez‐Beltran, R Montironi, L Wang, ... Histopathology 69 (1), 107-113, 2016 | 62 | 2016 |
| Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and … SN Kinney, JN Eble, O Hes, SR Williamson, DJ Grignon, M Wang, ... Modern Pathology 28 (9), 1236-1248, 2015 | 60 | 2015 |
| Abnormal expression of GADD45B in human colorectal carcinoma L Wang, X Xiao, D Li, Y Chi, P Wei, Y Wang, S Ni, C Tan, X Zhou, X Du Journal of translational medicine 10, 1-10, 2012 | 56 | 2012 |
| Significance of programmed death ligand 1 (PD-L1) immunohistochemical expression in colorectal cancer L Wang, F Ren, Q Wang, LA Baldridge, MF Monn, KW Fisher, W Sheng, ... Molecular diagnosis & therapy 20, 175-181, 2016 | 54 | 2016 |
| Epigenetic reprogramming with antisense oligonucleotides enhances the effectiveness of androgen receptor inhibition in castration-resistant prostate cancer L Xiao, JC Tien, J Vo, M Tan, A Parolia, Y Zhang, L Wang, Y Qiao, ... Cancer research 78 (20), 5731-5740, 2018 | 51 | 2018 |
| Fluorescence in situ hybridization in surgical pathology: principles and applications L Cheng, S Zhang, L Wang, GT MacLennan, DD Davidson The Journal of Pathology: Clinical Research 3 (2), 73-99, 2017 | 51 | 2017 |
Liang Cheng, MDIndiana University School of Medicine, Indianapolis, USAยืนยันอีเมลแล้วที่ iupui.edu